Edesa Biotech (EDSA) Finished Goods (2015)
Edesa Biotech (EDSA) posted Finished Goods of $377710.0 for Q3 2015, up 249.49% sequentially from $108074.0 in Q2 2015.
Edesa Biotech (EDSA) Finished Goods (2015) Analysis & Trends
Edesa Biotech has reported Finished Goods for 1 years, with the latest figure at $377710.0 in Q3 2015.
- Quarterly Finished Goods changed N/A year-over-year to $377710.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $377710.0 (changed N/A YoY) and the FY2015 annual result came in at $377710.0, changed N/A from the prior year.
- Finished Goods advanced to $377710.0 in Q3 2015 per EDSA's latest filing, from $108074.0 in the prior quarter.
- Over five years, Finished Goods peaked at $377710.0 in Q3 2015 and troughed at $108074.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Edesa Biotech | 40.44 Mn | 40.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 377,710.00 |
| Jun 30, 2015 | 108,074.00 |